{"filing":{"accession_number":"0001104659-26-087544","cik":"0001069899","ticker":"PAHC","company_name":"PHIBRO ANIMAL HEALTH CORP","form":"8-K","filing_date":"2026-07-28","report_date":"2026-07-28","primary_document":"tm2621206d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926087544/tm2621206d1_8k.htm"},"events":[{"id":21107,"run_id":19025,"accession_number":"0001104659-26-087544","anchor_item_number":"8.01","event_type":"dividend_distribution","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"The filing discloses a declaration of a quarterly cash dividend of $0.12 per share on Class A and Class B common stock, payable September 23, 2026. This is a routine but material capital allocation decision that affects shareholder value and is customarily disclosed in 8-K Item 8.01 filings with supporting press release exhibits.","company_name":"PHIBRO ANIMAL HEALTH CORP","ticker":"PAHC","filing_date":"2026-07-28","form":"8-K","submitted_at":null,"items":[{"id":20657,"accession_number":"0001104659-26-087544","item_number":"8.01","item_title":null,"event_type":"dividend_distribution","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"The filing discloses a declaration of a quarterly cash dividend of $0.12 per share on Class A and Class B common stock, payable September 23, 2026. This is a routine but material capital allocation decision that affects shareholder value and is customarily disclosed in 8-K Item 8.01 filings with supporting press release exhibits.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-28T20:19:19.074262+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":20657,"accession_number":"0001104659-26-087544","item_number":"8.01","item_title":null,"event_type":"dividend_distribution","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"The filing discloses a declaration of a quarterly cash dividend of $0.12 per share on Class A and Class B common stock, payable September 23, 2026. This is a routine but material capital allocation decision that affects shareholder value and is customarily disclosed in 8-K Item 8.01 filings with supporting press release exhibits.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-28T20:19:19.074262+00:00","company_name":"PHIBRO ANIMAL HEALTH CORP","ticker":"PAHC","filing_date":"2026-07-28"}]}
